Journal Article |
| Maples NJ, Copeland LA, Zeber JE, Li X, Moore TA, Dassori A, Velligan DI, Miller AL. Can medication management coordinators help improve continuity of care after psychiatric hospitalization? Psychiatr Serv 2012 Jun;63(6):554-560.
|
| Chakos M, Patel JK, Rosenheck R, Glick ID, Hammer MB, Tapp A, Miller A, Miller AL. Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study Clin Schizophr Relat Psychoses 2011 Oct;5(3):124-134.
|
| Velligan DI, Lopez L, Castillo DC, Manaugh B, Milam AC, Miller AL. The Inter-rater Reliability of Brief Standardized Outcome Measures in a Community Mental Health Setting: A move to Measurement-Based Care Psychiatric Services 2011 May;62(5):558-560.
|
| Miller AL. Implementing treatment guidelines Clin Schizophr Relat Psychoses 2011 Apr;5(1):15-16.
|
| Zeber JE, Miller AL, Copeland LA, McCarthy JF, Zivin K, Valenstein M, Greenwald D, Kilbourne AM. Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers Admin Policy Ment Health 2011 Mar;38(2):86-95.
|
| Zeber JE, Copeland, LA, Miller AL, Valenstein, M, Leykum LK. A Cost-Benefit Analysis of Higher Medication Copayments in Veterans with Schizophrenia Journal of Mental Health Policy and Economics 2011 Mar;14:S39-S39.
|
| Gonzalez JM, Corts DE, Reeves T, Whitley R, Lopez L, Bond GR, Velligan DI, Miller AL. Community Mental Health Agency Views of Research Community Ment Health J 2011 Mar;48(2):223-231.
|
| Chaves OC, Lombardo LE, Bearden CE, Woolsey MD, Martinez DM, Barrett JA, Miller AL, Velligan DI, Glahn DC. Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal study Bipolar Disord 2011 Feb;13(1):118-123.
|
| Dassori AM, Copeland LA, Zeber JE, Miller AL. Factors in Second-Generation Antipsychotic Switching Patterns in a National Sample of Older Veterans With Schizophrenia Psychiatric Services 2011 Jan;62(1):47-53.
|
| Copeland LA, Parchman ML, Zeber JE, Lawrence VA, Downs JR, Miller AL. Pre-diabetes assessment and follow-up in older veterans with schizophrenia. Epub PMID: 20808110 American Journal of Geriatric Psychiatry 2010 Jun;18(10):887-896.
|
| Miller AL, Dassori A, Lopez L, Castillo DA, Gonzalez JM, Boone C, Milam C, Bond GR, Velligan DI. Public-academic partnerships: tools for mental health agencies to evaluate research protocols Psychiatr Serv 2010 May;61(5):446-448.
|
| Taylor AC, Bond GR, Tsai J, Howard PB, El-Mallakh P, Finnerty M, Kealey E, Myrhol B, Kalk K, Adams N, Miller AL. Scales to evaluate quality of medication management: development and psychometric properties Adm Policy Ment Health 2009 Jul;36(4):247-254.
|
| Howard PB, El-Mallakh P, Miller AL, Rayens MK, Bond GR, Henderson K, Cooley AT. Prescriber fidelity to a medication management evidence-based practice in the treatment of schizophrenia Psychiatr Serv 2009 Jul;60(7):929-935.
|
| Velligan DI, Diamond P, Mueller J, Li X, Maples NJ, Wang M, Miller AL. The short term impact of generic versus individualized environmental supports on functional outcomes and target behaviors in schizophrenia Psychiatry Research 2009 Jan;168(2):94-101.
|
| Copeland LA, Zeber JE, Wang C, Parchman ML, Lawrence VA, Valenstein M, Miller AL. Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization BMC Health Serv Res 2009 Jan;9(127).
|
| Copeland, Laurel A., Miller AL, Welsh, Deborah E., McCarthy, John F., Zeber JE, Kilbourne, Amy M. Clinical and demographic factors associated with homelessness and incarceration among VA patients with bipolar disorder American Journal of Public Health 2009 Jan;99(5):871-877.
|
| Stroup TS, Lieberman JA, McEvoy JP, Davis SM, Swartz MS, Keefe RSE, Miller AL, Rosenheck RA, Hsiao JK. Results of phase 3 of the CATIE schizophrenia trial Schizophrenia Research 2009 Jan;107(1):1-12.
|
| Velligan DI, Diamond PM, Mintz J, Maples N, Li X, Zeber J, Ereshefsky L, Lam YW, Castillo D, Miller AL, Maples NJ. The Use of Individually Tailored Environmental Supports to Improve Medication Adherence and Outcomes in Schizophrenia Schizophrenia Bulletin 2008 May;34(3):483-493.
|
| Frey, WD, Azrin, ST, Goldman, HH, Kalasunas, S, Salkever, DS, Miller AL, Bond, GR, Drake, RE. The Mental Health Treatment Study Psychiatric Rehabilitation Journal 2008 Apr;31(4):306-312.
|
| Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA. A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia Neuropsychopharmacology 2008 Feb;33(3):465-472.
|
| Velligan DI, Diamond PM, Maples NJ, Mintz J, Xueying L, Glahn DC, Miller AL. Comparing the Efficacy of Interventions that use environmental supports to Improve Outcomes in Patients with Schizophrenia Schizophrenia Research 2008 Jan;102(1-3):312-319.
|
| Miller AL, Lopez L., Gonzalez JM, Dassori A., Bond G., Velligan DI. Public-Academic Partnerships: Research in Community Mental Health Settings: A Practicum Experience for Researchers Psychiatric Services 2008 Jan;59(11):1246-1248.
|
| Moore TA, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Essock SM, Finnerty M, Marder SR, Miller del D, McEvoy JP, Robinson DG, Schooler NR, Shon SP, Stroup TS, Miller AL. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update Journal of Clinical Psychiatry 2007 Nov;68(11):1751-1762.
|
| Buckley, PF, Correll CU, Miller AL. First-episode psychosis: a window of opportunity for best practices CNS Spectrums 2007 Sep;12(9 S15):1-12.
|
| Moore TA, Covell NH, Essock SM, Miller AL. Real-World Antipsychotic Treatment Practices Psychiatric Clinics of North America 2007 Sep;30(3):401-416.
|
Book Chapter |
| Miller AL, McEvoy J, Jeste D, Marder SR. Treatment of chronic schizophrenia. In: Lieberman, Jeffrey A [Ed]; Stroup, T. Scott [Ed]; Perkins, Diana O [Ed}. Essentials of schizophrenia. Arlington VA: American Psychiatric Publishing, Inc; 2012. p. 225-243.
|
| Moore TA, Kuipers E, Miller AL. Producing guidelines, protocols and toolkits. In: Szmukler G, Mueser K, Drake RE, Thornicroft G. Oxford Textbook of Community Mental Health. Oxford: Oxford University Press; 2011. |
Abstract |
| Castillo DC, Lopez LA, Manaugh B, Milam AC, Boone CH, Dassori AM, Velligan DI, Xi L, Scott L, Miller AL. Monitoring for metabloic syndrome in a community mental health center Abstractrs for the 13th International Congress on Schizophrenia Research (ICOSR); 2011 Mar. (Schizophrenia Bulletin; vol. 37, no. Sup 1).
|
| Velligan DI, Medellin EM, Castillo DA, Moore TA, Li X, Miller AL. VISTA: A novel psychosocial treatment to improve metabolic risk factors for patients on atypical antipsychotics Abstract for the 13th International Congress on Schizophrenia Research (ICOSR); 2011 Mar. (Schizophrenia Bulletin).
|
| Copeland LA, Zeber JE, Parchman ML, Downs JR, Miller AL, Lawrence VA. Prediabetes assessment and follow-up in older veterans with schizophrenia; 2010 Jun. (VA HSR&D National Meeting on Mental Health and Substance Use Disorders).
|
| Moore TA, Miller AL, Lopez L, Castillo D, Mintz J, Muenzler K, Li X, Pace P. High Utilizers of Inpatient State Hospital Services; 2009 Mar. (Schizophrenia Bulletin; vol. 35, no. 1).
|
| Miller AL, Velligan DI, Maples NJ, Li X, Copeland LA, Dassori AM, Moore TA, Mintz J, Zeber JE, Boone C, Evans L, Rodriguez J. Continuity of Care After Psychiatric Hospitalization; 2009 Jan. (Schizophrenia Bulletin; vol. 35, no. 1).
|
| Draper ML, Velligan DI, Maples NJ, Ritch JL, Li X, Miller AL. Environmental Supports and Technical Advances Improve Adherence to Medication in Schizophrenia; 2009 Jan. (Schizophrenia Bulletin; vol. 35, no. 1).
|
| Copeland LA, Zeber JE, Parchman ML, Lawrence VA, Hosek BJ, Miller AL. Pre-diabetes and diabetes assessment in veterans with schizophrenia [Oral Presentation]; 2009 Jan. (Schizophrenia Bulletin; vol. 35, no. S1).
|
| Velligan DI, Maples NJ, Ritch JL, Medellin EM, Li X, Miller AL, Mintz J. New research in psychosocial interventions for adherence: Prospective studies of the use of Environmental Supports vs. treatment as usual for improving adherence and outcome in multi-episode patients; 2009 Jan. (Schizophrenia Bulletin; vol. 35, no. 1).
|
| Maples NJ, Velligan DI, Ritch JL, Li X, Stutes D, Miller AL. Assessing the Ability to take Medication; 2009 Jan. (Schizophrenia Bulletin; vol. 35, no. 1).
|
| Robinson JL, Bearden, CE, Monkul, ES, Tordesillas-Gutierrez, D, Velligan DI, Miller AL, Frangou, S, Glahn DC. Abnormal Working Memory Network Response in Remitted Bipolar Disorder; 2008 Apr. (Biological Psychiatry; vol. 63, no. 7S).
|
| Zeber JE, Copeland LA, Miller AL, Kilbourne AM, Velligan DI, Mortensen EM. Ethnicity and the impact of higher medication copayments among veterans with schizophrenia: International Society for Pharmacoeconomics & Outcomes Research; 2008 Jan. (Value in Health; vol. 11, no. 3).
|
Electronic/Web Publication |
| Gonzalez JM, Velligan DI, Lopez L, Mintz J, Bond GR, Miller AL. Academic-Community Partnership: An Orientation for Employees of a Community Mental Health Agency to Its Research Program 2010 Aug. Available from: www.educationforhealth.net . |